PL330864A1 - Orally administered composition containing antimycotic compounds of triazole - Google Patents

Orally administered composition containing antimycotic compounds of triazole

Info

Publication number
PL330864A1
PL330864A1 PL97330864A PL33086497A PL330864A1 PL 330864 A1 PL330864 A1 PL 330864A1 PL 97330864 A PL97330864 A PL 97330864A PL 33086497 A PL33086497 A PL 33086497A PL 330864 A1 PL330864 A1 PL 330864A1
Authority
PL
Poland
Prior art keywords
triazole
composition containing
orally administered
administered composition
antimycotic compounds
Prior art date
Application number
PL97330864A
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL330864A1 publication Critical patent/PL330864A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
PL97330864A 1996-06-28 1997-06-25 Orally administered composition containing antimycotic compounds of triazole PL330864A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28

Publications (1)

Publication Number Publication Date
PL330864A1 true PL330864A1 (en) 1999-06-07

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97330864A PL330864A1 (en) 1996-06-28 1997-06-25 Orally administered composition containing antimycotic compounds of triazole

Country Status (16)

Country Link
EP (1) EP0914100A1 (en)
JP (1) JP2000514059A (en)
KR (1) KR20000022294A (en)
CN (1) CN1228693A (en)
AU (1) AU731704B2 (en)
BR (1) BR9710069A (en)
CA (1) CA2258683C (en)
CZ (1) CZ421498A3 (en)
HU (1) HUP9903869A3 (en)
IL (1) IL127780A0 (en)
NO (1) NO986087L (en)
NZ (1) NZ333514A (en)
PL (1) PL330864A1 (en)
SK (1) SK177598A3 (en)
TR (1) TR199802718T2 (en)
WO (1) WO1998000116A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03904B1 (en) * 1997-03-26 2002-12-16 Janssen Pharmaceutica N.V. Granule, pharmaceutical dosage form, method of preparation of the granules and drug-coated granules
CA2301042A1 (en) * 1998-06-11 1999-12-16 Em Industries, Inc. Micro-osmotic controlled drug delivery systems
DE69927163T2 (en) * 1998-07-17 2006-06-29 Janssen Pharmaceutica N.V. GRANULATE WITH A FUNGICIDE AND A POLYMER COVERED CORE
ES2157731B1 (en) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada ORAL PHARMACEUTICAL PREPARATION OF AN ANTIFUNGIC ACTIVITY COMPOUND AND PROCEDURE FOR PREPARATION.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (en) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
KR100694667B1 (en) * 1999-12-08 2007-03-14 동아제약주식회사 Antifungal compositions containing itraconazole with both improved bioavailability and narrow intra- and inter-individual variation of its absorption
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
FR2842736B1 (en) 2002-07-26 2005-07-22 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF A PLURALITY OF MICROCAPSULES FOR PROLONGED RELEASE OF LOW SOLUBLE ACTIVE (S) PRINCIPLE (S)
ITMI20031096A1 (en) * 2003-05-30 2004-11-30 Eurand Spa MICROCAPS FOR COACERVATION CONTAINING DRUG INCORPORATED IN THE COATING POLYMER
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN105949278B (en) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 Substituted tetrahydrofuran water-soluble derivative and application thereof
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
ATE204875T1 (en) * 1993-12-21 2001-09-15 Schering Corp FUNGICIDAL TETRAHYDROFURANES

Also Published As

Publication number Publication date
EP0914100A1 (en) 1999-05-12
AU3387497A (en) 1998-01-21
CZ421498A3 (en) 1999-06-16
TR199802718T2 (en) 1999-03-22
JP2000514059A (en) 2000-10-24
NZ333514A (en) 2000-05-26
HUP9903869A3 (en) 2000-07-28
WO1998000116A1 (en) 1998-01-08
IL127780A0 (en) 1999-10-28
CN1228693A (en) 1999-09-15
AU731704B2 (en) 2001-04-05
KR20000022294A (en) 2000-04-25
SK177598A3 (en) 1999-07-12
CA2258683C (en) 2007-07-31
HUP9903869A2 (en) 2000-06-28
BR9710069A (en) 1999-08-10
CA2258683A1 (en) 1998-01-08
NO986087D0 (en) 1998-12-23
NO986087L (en) 1999-02-26

Similar Documents

Publication Publication Date Title
PL330864A1 (en) Orally administered composition containing antimycotic compounds of triazole
AU4010395A (en) Compositions for increased bioavailability of orally delivered therapeutic agents
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
HUP0001219A3 (en) Pharmaceutical compositions containing compounds of neurotrophic effect
IL195339A0 (en) Solid oral dosage forms of valsartan
PL311918A1 (en) Composition for external application containing an antagonist of p substance
PL330931A1 (en) Antimycotic agents of improved bioavailability
PL337738A1 (en) Novel substituted compounds of imidazole
IL117237A0 (en) Pharmaceutical composition for piperidinoalkanol compounds
ZA987552B (en) Pharmaceutical composition for combination of piperidino-alkanol-decongestant
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
PL324341A1 (en) Pharmaceutic compositions and compounds
PL339461A1 (en) Orally administered compositions containing levosimendane
ZA9510427B (en) Pharmaceutical orally applicable composition
ZA9510428B (en) Pharmaceutical orally applicable composition
HUP0104657A3 (en) Imidazole compounds and pharmaceutical compositions containing them
IL118425A0 (en) Pharmaceutical composition containing 1H-1,2,4-triazole derivative
PL315666A1 (en) Heterocyclic compounds of therapeutic properties
IL113248A0 (en) Use of alpha - 1c specific compounds
HUT74746A (en) Pharmaceutical compositions containing p antagonist
AU3481795A (en) Pharmaceutical compositions containing d2o
AU1897795A (en) X-ray contrast compositions containing pharmaceutically acceptable clays
AU4019395A (en) Use of amino-isoxazolidone compounds for improvement of implicit memory
GB2315218B (en) Fungicidal composition based on 2 compounds of triazole type
AU4959497A (en) Pharmaceutical composition containing bismuth-polyacrylic acid compounds